US FDA opens new Mexico office
This article was originally published in RAJ Devices
The US Food and Drug Administration has opened an office in Mexico City as part of its efforts to improve food and medical product safety by working with its regulatory partners abroad1. This is the agency’s third post in Latin America and its tenth international post in the past 13 months.
You may also be interested in...
Sanofi failed in its attempt to have its EU marketing authorization application for avalglucosidase alfa fast-tracked through the centralized review process at the European Medicines Agency. This and other developments relating to the agency's accelerated assessment mechanism are logged in this latest update to the Pink Sheet's EU accelerated assessment tracker.
Change in leadership at the European Medicines Agency comes at a critical time.
The change in leadership at the European Medicines Agency comes at a critical time.